1. Hairy Cell Leukemia Variant Has Similar Survival to Classical Disease Despite Poorer Responses to Initial Therapy: A 30-Year Experience from Memorial Sloan Kettering Cancer Center by Bartlomiej Getta, Kaitlin M Woo, Sean Devlin, Jae H. Park, Omar Abdel-Wahab, and Martin S Tallman Blood Volume 126(23):1476-1476 December 3, 2015 ©2015 by American Society of Hematology

2. OS for classical and variant HCL is equal despite the shorter remission duration and more frequent need for re-treatment in HCL variant. Bartlomiej Getta et al. Blood 2015;126:1476 ©2015 by American Society of Hematology

3. Remission duration following first therapy is significantly longer in patients with classical than variant HCL. Bartlomiej Getta et al. Blood 2015;126:1476 ©2015 by American Society of Hematology